The Deal

OCTOBER 17, 2023

On the latest episode of The Deal’s Behind the Buyouts podcast, Solomon Partners co-head of consumer and retail Cathy Leonhardt talks about the sector’s slow start to M&A this year, categories that continue to shine and potential signs of a resurgence in dealmaking. portfolio company Birkenstock GmbH & Co. .”

M&A 64

M&A IPO Retail Medical 64

Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 23, 2024

In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024. Big pharma dominated life sciences M&A, with more than two-thirds (69%) of M&A investment coming from big pharma, compared to just 38% in 2022.

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52

Focus Investment Banking

SEPTEMBER 24, 2024

Across more than 100 M&A transactions over the course of his career, Jonathan Wilfong has played a role in impacting thousands of lives. These required M&A transactions to bring 75 medical practices together in the two firms. Their combined IPO capitalizations exceeded $125 million.

Transportation 52

Transportation Manufacturing Medical M&A 52

Mergers and Inquisitions

NOVEMBER 1, 2023

The short answer to #1 is that healthcare private equity firms operate in specific verticals with stable-ish cash flows, such as healthcare services, nursing facilities, medical devices, equipment, and healthcare IT. Why do PE firms operate there? Don’t they need companies with stable cash flows? For example, in the U.S.,

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Global Newswire by Notified: M&A

OCTOBER 20, 2024

euros per share, up 40% from its initial IPO price of 6.00 VIROO provides multiple ready-to-use applications for users, as well as tools for developers to create and distribute their own custom multi-user XR applications and is currently used to simulate nuclear plants, railway infrastructures, and medical facilities. million euros.

Shares 56

Shares Education Corporation IPO 56

Peak Frameworks

SEPTEMBER 19, 2023

For example, in the 2012 Facebook IPO, common shareholders gained exposure to the tech giant's fortunes, while also securing a say in corporate matters. The distinction between them is crucial for understanding a company's obligations, its strategy, and the interplay of interests within its ecosystem. What is a Shareholder?

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52